Search Browse Earnings

IRADIMED CORP — SlamSEC

IRADIMED CORP

Nasdaq:IRMD

Surgical & Medical Instruments & Apparatus·ORLANDO, FL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$73.2M

+11.7% YoY

FY 2025

Adj. EBITDA

$22.8M

31.1% margin

FY 2025

Net Income

$19.2M

26.3% margin

FY 2025

EPS (Diluted)

$1.50

FY 2025

Stock Price

$100.81

+1.9%

2026-03-11

52W Range

$47.48 – $107.90

P/E Ratio

67.2x

Market Cap

$1.3B

Cash

$52.2M

FY 2025

Total Debt

—

Net Cash

$52.2M

FY 2025

Enterprise Value

$1.2B

Debt / EBITDA

-2.3x

FY 2025

EV / EBITDA

54.3x

Employees

—